Djibouti vs Timor-Leste: Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology
Djibouti
1.0%
in 2024
Timor-Leste
1.0%
in 2024
Djibouti rank
34th
Timor-Leste rank
34th
Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology over time
- Djibouti
- Timor-Leste
How they compare
Djibouti currently reports 1.0% against 1.0% in Timor-Leste, a difference of 0.0%.
Across all 10 years both countries report, Timor-Leste has been ahead every year.
Djibouti ranks 34th and Timor-Leste ranks 34th of 247 countries.
Timor-Leste has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Djibouti | Timor-Leste | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 1.0% | 2.5% | 1.5% | Timor-Leste |
| 2020s | 1.0% | 1.3% | 0.3% | Timor-Leste |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence of hepatitis b surface antigen (hbsag), 2026 methodology, Djibouti or Timor-Leste?
- Djibouti, at 1.0% against 1.0% in Timor-Leste as of 2024.
- What is the difference in prevalence of hepatitis b surface antigen (hbsag), 2026 methodology between Djibouti and Timor-Leste?
- 0.0%, with Djibouti ahead.
- How many years of comparable data are there for Djibouti and Timor-Leste?
- 10 years are reported by both, from 2015 to 2024.
- How do Djibouti and Timor-Leste rank globally for prevalence of hepatitis b surface antigen (hbsag), 2026 methodology?
- Djibouti ranks 34th and Timor-Leste ranks 34th of 247 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.